Yunkai Zhang - Search Results

Year	Number of Results
2005	3
2009	1
2010	2
2011	3
2012	3
2013	4
2014	16
2015	9
2016	3
2017	11
2018	8
2019	9
2020	8
2021	5
2022	4
2023	11

1

Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis.

Dong Y, Hu H, Zhang X, Zhang Y, Sun X, Wang H, Kan W, Tan MJ, Shi H, Zang Y, Li J. Dong Y, et al. Among authors: zhang y. Signal Transduct Target Ther. 2023 Mar 6;8(1):95. doi: 10.1038/s41392-022-01302-6. Signal Transduct Target Ther. 2023. PMID: 36872368 Free PMC article.

2

Multidrug Resistance Proteins (MRPs) and Cancer Therapy.

Zhang YK, Wang YJ, Gupta P, Chen ZS. Zhang YK, et al. AAPS J. 2015 Jul;17(4):802-12. doi: 10.1208/s12248-015-9757-1. Epub 2015 Apr 4. AAPS J. 2015. PMID: 25840885 Free PMC article. Review.

3

The development and benefits of metformin in various diseases.

Dong Y, Qi Y, Jiang H, Mi T, Zhang Y, Peng C, Li W, Zhang Y, Zhou Y, Zang Y, Li J. Dong Y, et al. Among authors: zhang y. Front Med. 2023 Jun;17(3):388-431. doi: 10.1007/s11684-023-0998-6. Epub 2023 Jul 4. Front Med. 2023. PMID: 37402952 Review.

4

ABCG2 Overexpression Contributes to Pevonedistat Resistance.

Kathawala RJ, Espitia CM, Jones TM, Islam S, Gupta P, Zhang YK, Chen ZS, Carew JS, Nawrocki ST. Kathawala RJ, et al. Cancers (Basel). 2020 Feb 12;12(2):429. doi: 10.3390/cancers12020429. Cancers (Basel). 2020. PMID: 32059437 Free PMC article.

5

Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II.

Su CY, Yan YY, Zhang JY, Zhang YK, Chen ZS. Su CY, et al. Front Pharmacol. 2023 Jun 30;14:1147488. doi: 10.3389/fphar.2023.1147488. eCollection 2023. Front Pharmacol. 2023. PMID: 37456736 Free PMC article. No abstract available.

6

The reversal of antineoplastic drug resistance in cancer cells by β-elemene.

Zhang GN, Ashby CR Jr, Zhang YK, Chen ZS, Guo H. Zhang GN, et al. Chin J Cancer. 2015 Sep 14;34(11):488-95. doi: 10.1186/s40880-015-0048-0. Chin J Cancer. 2015. PMID: 26370907 Free PMC article. Review.

7

Structure-Guided Strategies of Targeted Therapies for Patients with EGFR-Mutant Non-Small Cell Lung Cancer.

Du Z, Sun J, Zhang Y, Hesilaiti N, Xia Q, Cui H, Fan N, Xu X. Du Z, et al. Among authors: zhang y. Biomolecules. 2023 Jan 20;13(2):210. doi: 10.3390/biom13020210. Biomolecules. 2023. PMID: 36830579 Free PMC article. Review.

8

Novel Marine Secondary Metabolites Worthy of Development as Anticancer Agents: A Review.

Mbaoji FN, Nweze JA, Yang L, Huang Y, Huang S, Onwuka AM, Peter IE, Mbaoji CC, Jiang M, Zhang Y, Pan L, Yang D. Mbaoji FN, et al. Among authors: zhang y. Molecules. 2021 Sep 23;26(19):5769. doi: 10.3390/molecules26195769. Molecules. 2021. PMID: 34641312 Free PMC article. Review.

9

Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance.

Wang YJ, Zhang YK, Kathawala RJ, Chen ZS. Wang YJ, et al. Cancers (Basel). 2014 Sep 29;6(4):1925-52. doi: 10.3390/cancers6041925. Cancers (Basel). 2014. PMID: 25268163 Free PMC article. Review.

10

KAT8 selectively inhibits antiviral immunity by acetylating IRF3.

Huai W, Liu X, Wang C, Zhang Y, Chen X, Chen X, Xu S, Thomas T, Li N, Cao X. Huai W, et al. Among authors: zhang y. J Exp Med. 2019 Apr 1;216(4):772-785. doi: 10.1084/jem.20181773. Epub 2019 Mar 6. J Exp Med. 2019. PMID: 30842237 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

87 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year